emergence from the pupal case as adults). As compared containing tau are identified in many FTD cases, and to wild-type ( Figure 1A) , the gl-tau eyes were reduced hyperphosphorylated filamentous tau comprises the in size and displayed a rough phenotype in anterior NFT that are a pathological hallmark of PSP and AD regions, while posterior aspects appeared normal (Fig-(Houlden et al., 1999 ; Goedert et al., 1998; Lee et al., ure 1B). Analysis using scanning electron microscopy 2001). Therefore, understanding the events that modify (SEM) revealed fused and disordered ommatidia with tau-associated neurodegenerative processes is impormissing, irregular, and occasional supernumerary mechtant to further our understanding of the pathophysiology anosensory bristles. Flies expressing two copies of the of these diseases and may have relevance for theratransgene had severely reduced eyes ( Figure 1C ). peutics.
ure 1B). Analysis using scanning electron microscopy 2001). Therefore, understanding the events that modify (SEM) revealed fused and disordered ommatidia with tau-associated neurodegenerative processes is impormissing, irregular, and occasional supernumerary mechtant to further our understanding of the pathophysiology anosensory bristles. Flies expressing two copies of the of these diseases and may have relevance for theratransgene had severely reduced eyes ( Figure 1C ). peutics.
In order to determine at what stage the onset of the Many FTD mutations occur in regulatory elements that abnormal phenotype occurs, the larval eye imaginal disc alter splicing and, thereby, expression of tau isoforms, (the primordium of the adult eye) was examined using immunohistochemical staining for the neuronal nuclear protein Elav (Robinow and White, 1988). In third instar 
larval eye discs expressing two copies of the tau trans-␤-catenin), thus targeting it for degradation via the ubiquitin-proteasome pathway (Pai et al., 1997).
We assessed gene, early cell loss, and irregularities in differentiating neurons were apparent soon after tau transgene expresinteractions between tau and the wingless pathway, using several transgenes and loss-of-function mutations. sion commenced (Figure 1E ), compared with the control shown in Figure 1D . Staining using an antibody directed Transgenes were expressed using the binary GAL4/UAS system (Brand and Perrimon, 1993), allowing us to target against lamin Dm 0 (a homolog of lamin B) (Smith et al., 1987) demonstrated abnormal accumulation of lamin, their expression to cell populations overlapping with those expressing tau. In a background heterozygous for which is indicative of nuclear envelope breakdown (Figure 1E) , a caspase-mediated process occurring in apoa hypomorphic allele of shaggy, the tau eye phenotype was ameliorated, producing larger eyes with a more ptotic nuclei (Oberhammer et al., 1994; Lazebnik et al., 1995; McCall and Steller, 1998) . Loss of photoreceptor normal ommatidial array except at the most anterior margin of the eye (data not shown). This effect was neurons and disorganization of the normal ( Figure 1F ) ommatidial architecture is observed in flies expressing subtle when the effect of the shaggy loss-of-function was assessed in conjunction with one copy of the tau two copies of the tau transgene ( Figure 1G) . Analysis of the underlying medulla, the second optic ganglion, transgene, but was dramatic when the transgene copy number was increased; two copies of gl-tau produced demonstrated numerous vacuoles ( Figures 1H and 1I ). Vacuolization has also been observed in a fly model of a severely reduced eye phenotype (Figure 2A) , which was dramatically suppressed in a background heterozyneurodegeneration due to overexpression of wild-type or the FTD-causing R406W tau mutation, where the apgous for a loss-of-function mutation in shaggy ( Figure  2B ). We employed a pan-neural driver that had been pearance of vacuoles was correlated with neurodegeneration (Wittmann et al., 2001). Here, comparison of the exploited previously to examine effects of shaggy overexpression in the eye (Ahmed et al., 1998), the elavpattern of vacuolization with that of tau expression in the medulla was assessed using T14, (Kosik et al., 1988) GAL4 C155 line (Lin and Goodman, 1994). In trans to elav-GAL4, UAS-shaggy had no visible external phenotype a monoclonal antibody recognizing an amino terminal epitope of human tau ( Figure 1J ). Vacuolization was most other than mildly disordered bristles (data not shown).
In the presence of gl-tau, however, shaggy exerted a prominent in the medulla, where tau immunoreactivity was confined to axons of photoreceptors R7 and R8. dramatic effect. Coexpression of tau throughout the retina, in combination with pan-neural expression of shaggy, resulted in a markedly reduced eye with com-GSK-3␤/shaggy Modulates Tau-Induced plete loss of normal ommatidia and the majority of brisNeurodegeneration and NFT-Like Aggregates tles ( Figure 2D ). A major source of tau phosphorylation in brain is the We examined the retinal localization of tau coexserine-threonine kinase, GSK-3␤, the human homolog pressed with shaggy using the monoclonal antibody of Drosophila shaggy/zeste white-3 (Perrimon and Ma-AT100, which recognizes a phosphorylated epitope howald, 1987). Shaggy is a component of the wingless unique to tau within PHF (Matsuo et al., 1994). AT100 signaling pathway (Willert and Nusse, 1998) and serves to phosphorylate Armadillo (the Drosophila homolog of staining is specific for intraneuronal and extraneuronal (Figures 2G and 2H) .
The appearance of fibrillar phosphotau aggregates concurrently with the fly heads is approximately 290 nm long and 20 nm wide ( Figure 3E ), consistent with with shaggy misexpression correlated with increased tau immunoreactivity with AT100 using immunoblots of previous measurements in postmortem brain. Thus, phosphorylation of human tau by the Drosophila GSK-3 gl-tau heads ( Figure 3A) . Minimal AT100 tau immunoreactivity was observed in the gl-tau flies alone, whereas homolog Shaggy resulted in the formation of neurofibrillary pathology, including straight filaments and PHF, a more abundant signal was observed with heads coexpressing gl-tau and shaggy, correlating with the immuwhereas these structures were not observed in flies overexpressing tau alone. nohistochemical presence of fibrillar aggregates of tau. Electron microscopy of insoluble extracts was perGiven the enhanced rough eye phenotype and appearance of neurofibrillary-like aggregates containing formed to ascertain the conformation of the filamentous tau-containing aggregates. Filament formation was not hyperphosphorylated tau in flies coexpressing tau and shaggy, we sought to determine the relationship beobserved in the wild-type background or in flies expressing gl-tau alone. In the presence of both the tau and tween the appearance of AT100 immunoreactivity and neurodegeneration. In third instar larval eye discs exshaggy transgenes, however, filamentous structures, including PHF showing a characteristic periodicity similar pressing one copy of gl-tau, only subtle irregularities notype. enable genetic screening for modifiers of tau-associated neurodegeneration. We tested for genetic interactions between tau-induced neurodegeneration and the Wnt pathway using GSK-3␤ and two additional components, ␤-catenin/armadillo and dTCF, which are downstream of GSK-3␤. Overexpression of wild-type htau4R in Drosophila resulted in degeneration without apparent accumulation of NFT, as observed in previous models (Williams et al., 2000; Wittmann et al., 2001) . However, we observed that tau hyperphosphorylation by the Drosophila GSK-3␤ homolog Shaggy exacerbated tau-induced neurodegeneration, resulting in the formation of NFT-like filamentous tau aggregates, thus showing a causal relationship between tau hyperphosphorylation and neurofibrillary pathology in vivo. These findings suggest that tau phosphorylation by the fly GSK-3␤ homolog has a direct influence on the aggregation of tau in vivo, which is likely independent of its classical Wnt role (i.e., enhancement of ␤-catenin degradation). These data further In the absence of the Wnt signal, GSK-3␤ phosphorylasuppressed the gl-tau phenotype ( Figure 7A ), resulting in restoration of the eye toward wild-type size with a tion of ␤-catenin leads to its degradation and thus impairs the ability of ␤-catenin to serve as a coactivator less rough external appearance (Figures 7B-7D) . The ability of the apoptotic inhibitor transgenes to suppress of the transcription factor TCF. Therefore, if GSK-3␤ overexpression were exerting its tau-modifying effect the tau phenotype was incomplete but comparable to that of the heterozygous armadillo mutations. These indirectly via enhancement of ␤-catenin phosphorylation, loss of ␤-catenin or TCF function would mirror the data, in conjunction with abnormalities observed in the pattern of nuclear lamin staining, strongly support a role effect of GSK-3␤ overexpression. In contrast, increased ␤-catenin or TCF activity, as it occurs following Wnt for apoptosis in tau-induced neurodegeneration.
binding to its receptor, would be expected to exert an effect opposite to that of GSK-3␤ overexpression.
Discussion
This was not observed. Instead, increased expression of either ␤-catenin/armadillo or TCF enhanced the tauHere, human tau was overexpressed in the Drosophila eye to create a model of neurodegeneration based on induced neurodegenerative phenotype, whereas lossof-function mutations in ␤-catenin/armadillo or TCF perturbation of wild-type tau expression, as well as to NFT are a defining characteristic of several neurodegenerative disorders (including AD and PSP) and are a roEnhancement of tau aggregation following GSK-3␤ phosphorylation was also observed in a mouse model bust and scorable marker, neurofibrillary pathology (such as that described here) is likely to prove useful in of inducible GSK-3␤ overexpression in the presence of wild-type murine tau in which increased insoluble tau screening for disease modifiers. It is unlikely that any single experimental model will faithfully recapitulate all and pretangles were observed without NFT per se (Lucas et al., 2001) . This observation agrees with data repathologic features of complex neurodegenerative conditions in humans. Nonetheless, these findings, using a ported here, demonstrating that the combination of GSK-3␤ overexpression and wild-type tau dysregulation genetically pliable organism, provide impetus for extending and confirming our observations in mammalian produces neurofibrillary pathology. Axonopathy, tau hyperphosphorylation, and pretangle formation have systems. also been observed in mice overexpressing wild-type htau4R in the absence of GSK-3␤ activation, consistent
Comparison to Previous Fly Models with the mild tau phosphorylation observed in gl-tau
The neurodegenerative phenotype observed in this flies. Surprisingly, constitutive GSK-3␤ activation and study with wild-type tau overexpression appeared as wild-type 4R tau phosphorylation actually ameliorated severe as that seen previously with mutant tau overexthe pathology in another transgenic model ( 
